{
    "2018-03-25": [
        [
            {
                "time": "",
                "original_text": "药明康德: 独角兽美国退市回归 私有化成最棘手问题",
                "features": {
                    "keywords": [
                        "药明康德",
                        "独角兽",
                        "美国退市",
                        "私有化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德27日上会 参股公司受关注",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上会",
                        "参股公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}